Latest filing published 19 May 2017 for REVA Medical, Inc., €328k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert K. Schultz: trading record in brief
This profile gathers the share dealings of Robert K. Schultz in REVA Medical, Inc. The record holds 7 filings, for trades running from 29 August 2011 to 17 May 2017.
Both buying and selling appear: 1 purchase worth €23k, against 1 sale worth €328k. Sales outweigh purchases by €305k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 3 share grants and 2 option exercises. Since January 2017: no purchases and 1 sale on the market.
The record was last updated on 19 May 2017 with an open-market sale (€328k) in REVA Medical, Inc. The most recent open-market purchase was published on 30 August 2011, 5,550 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert K. Schultz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 55,000 shares@ US$6.66100.0% of flowCommon StockSEC:0001209191-17-034059:0
- 20,500 shares0Common StockSEC:0001209191-17-022403:0
- 80,000 shares@ US$1.25Common StockSEC:0001209191-15-060355:0
- 85,000 shares@ US$1.00Common StockSEC:0001209191-14-002968:0
- 20,000 shares0Common StockSEC:0001209191-13-003298:0
- 16,500 shares0Common StockSEC:0001209191-12-038706:0
- 5,000 shares@ US$6.77Common StockSEC:0001209191-11-046050:0Canonical exit: 27 Nov 2011 (T+90)
7 of 7 declarations